Mesothelioma Cancer Resources Blog

Early Results of Clinical Trial for Defactinib Show Promise for Mesothelioma Patients
This article is a correction from the original that inadvertently stated that defactinib was approved by the U.S. FDA. It should have said paclitaxel was approved by the FDA. In November, MesotheliomaHelp announced the start of the global clinical trial named COMMAND (Control Of Mesothelioma with MAiNtenance Defactinib), to assess the overall survival and progression …

Read More

Label: Featured Story Research News
Posted on Monday, Jun 16, 2014

For free, no obligation, information to review with your family, please complete this quick request form:

Mike Dayton Mike is a licensed attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly. He has contributed numerous articles to the North Carolina State Bar Journal and is a co-author of Capital Lawyers, a history of the Wake County (NC) Bar.
Gregory Froom Gregory Froom is a licensed North Carolina attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly.
Nancy Meredith Nancy is a blog writer with more than 20 years of professional experience in the Information Technology industry. She lives in Wake Forest, N.C.